Research suggests that sustained muscle activity, such as prolonged calf movements, significantly reduces post-meal glucose levels more than brief exercises like seated heel raises. The most effective approach remains a moderate walk soon after eating, highlighting the importance of timing…
Emerging research underscores the importance of consuming fibre-rich, low-carbohydrate vegetables such as broccoli, leafy greens, and Brussels sprouts to help prevent blood sugar spikes and support diabetes management, reinforcing dietary strategies recommended by health authorities. Keeping blood sugar on an…
While recent studies suggest a potential link between GLP-1 receptor agonists and rare optic nerve damage, eye specialists emphasise that the overall risk remains extremely low and current treatment guidelines favour continued use with vigilance. Evidence from recent studies suggests…
A recent study presented in Milan indicates that very low-carbohydrate diets may improve blood sugar control and reduce insulin needs in children with type 1 diabetes without immediate safety concerns, though longer-term research is needed. Very low-carbohydrate diets may help…
A new triple-hormonal drug, retatrutide, demonstrates substantial weight loss and improved blood glucose control in its largest trial to date, signalling potential for a breakthrough in obesity and type 2 diabetes treatment, though regulatory approval is still pending. Retatrutide, an…
With over 600,000 residents in South Carolina living with diabetes, legal experts emphasise the importance of proper diagnosis and timely treatment to prevent serious health complications and potential malpractice claims. Type 2 diabetes is a common long-term condition, but the…
Paediatric experts emphasise the importance of children with diabetes having immediate access to blood glucose monitors and quick-acting sugars at school to ensure prompt response to hypoglycaemia and hyperglycaemia symptoms, safeguarding their health and well-being. Children with diabetes should be…
Eli Lilly reports promising phase 2b results for a novel drug combo of eloralintide and tirzepatide, noting improved weight reduction and diabetes management in adults with obesity, paving the way for phase 3 trials. Eli Lilly’s experimental amylin receptor agonist…
Eli Lilly’s phase 2b trial reveals that combining the amylin receptor agonist eloralintide with tirzepatide results in greater weight loss and blood sugar control in adults with type 2 diabetes and obesity, prompting plans for phase 3 development. Eli Lilly…
Eight international organisations have unified to establish the Global Alliance for Diabetic Foot Survival and Limb Preservation, seeking to reduce preventable amputations and elevate diabetic foot care on the global health agenda amid alarming mortality rates. Eight organisations from across…
